![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/4152 | (2006.01) |
A61K 9/08 | (2006.01) | ||
A61K 9/20 | (2006.01) | ||
A61K 9/48 | (2006.01) | ||
A61P 25/00 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
A61P 25/28 | (2006.01) | ||
A61K 39/395 | (2006.01) |
(11) | Patento numeris | 3216447 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 15857765.0 |
Europos patento paraiškos padavimo data | 2015-11-05 | |
(97) | Europos patento paraiškos paskelbimo data | 2017-09-13 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-06-02 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/CN2015/093837 |
Data | 2015-11-05 |
(87) | Numeris | WO 2016/070817 |
Data | 2016-05-12 |
(30) | Numeris | Data | Šalis |
201410618300 | 2014-11-05 | CN |
(72) |
WANG, Yanjiang , CN
JIAO, Shusheng , CN
YAO, Xiuqing , CN
ZHOU, Xinfu , AU
|
(73) |
The Third Affiliated Hospital
Third Military Medical University, PLA ,
10 Changjiang Branch Road
Daping, Yuzhong District, Chongqing 400042,
CN
|
(54) | USE OF EDARAVONE IN PREPARING DRUG FOR PREVENTING AND TREATING CEREBRAL AMYLOID ANGIOPATHY (CAA) |
USE OF EDARAVONE IN PREPARING DRUG FOR PREVENTING AND TREATING CEREBRAL AMYLOID ANGIOPATHY (CAA) |